---
title: "WuXi AppTec Co., Ltd. (603259.SH)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/603259.SH.md"
symbol: "603259.SH"
name: "WuXi AppTec Co., Ltd."
industry: "Life Sciences Tools and Services"
datetime: "2026-05-19T17:25:19.894Z"
locales:
  - [en](https://longbridge.com/en/quote/603259.SH.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/603259.SH.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/603259.SH.md)
---

# WuXi AppTec Co., Ltd. (603259.SH)

## Company Overview

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally. The company operates through WuXi Chemistry, WuXi Testing, WuXi Biology, and Others segments. It offers contract research, development, and manufacturing organization (CDRMO) services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions which support stand-alone and integrated projects from target discovery to candidate selection and into the clinic. The company also provides laboratory testing services, such as toxicology, DMPK, and bioanalytical services; clinical contract research organization services, including Phase I to Phase IV clinical development services, and bioequivalence for products including pharmaceuticals and biologics; and site management organization, patient recruitment, site start-up, and academic research organization.

| Item | Detail |
|------|--------|
| Industry | Life Sciences Tools and Services |
| Exchange | CN Market |
| Website | [www.wuxiapptec.com.cn](https://www.wuxiapptec.com.cn) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:08.000Z

**Overall: B (0.26)**

**Industry**: Life Sciences Tools and Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 1 / 25 |
| Industry Median | B |
| Industry Average | C |

- **Style**: Growth - Stocks whose main business is in the growth stage.
- **Scale**: Large - The company has stable operations, allowing for dependable long-term returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 23.40% |  |
| Net Profit YoY | 80.05% |  |
| P/B Ratio | 3.62 |  |
| Dividend Ratio | 1.60% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 304201653778.93 |  |
| Revenue | 46157886088.47 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 25.66% | A |
| Profit Margin | 43.57% | A |
| Gross Margin | 50.40% | B |
| Revenue YoY | 23.40% | A |
| Net Profit YoY | 80.05% | A |
| Total Assets YoY | 27.10% | A |
| Net Assets YoY | 35.03% | A |
| Cash Flow Margin | 87.45% | C |
| OCF YoY | 23.40% | A |
| Turnover | 0.48 | C |
| Gearing Ratio | 21.08% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - WuXi AppTec Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "23.40%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "80.05%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "3.62",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "1.60%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "304201653778.93",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "46157886088.47",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "25.66%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "43.57%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "50.40%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "23.40%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "80.05%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "27.10%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "35.03%",
          "rating": "A"
        },
        {
          "name": "Cash Flow Margin",
          "value": "87.45%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "23.40%",
          "rating": "A"
        },
        {
          "name": "Turnover",
          "value": "0.48",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "21.08%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 15.09 | 1/25 | 20.88 | 18.72 | 16.65 |
| PB | 3.61 | 16/25 | 4.62 | 3.96 | 3.72 |
| PS (TTM) | 6.30 | 13/25 | 6.92 | 6.40 | 6.08 |
| Dividend Yield | 1.60% | 1/25 | 1.79% | 1.66% | 1.47% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | WuXi AppTec (603259.SH) | A | A | C | A | B | B |
| 02 | Pharmaron (300759.SZ) | B | B | C | B | B | B |
| 03 | Chemexpress (688131.SH) | B | B | C | C | B | B |
| 04 | HitGen (688222.SH) | B | A | D | B | C | B |
| 05 | GEMPHARMATECH (688046.SH) | B | B | D | A | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-17T16:00:00.000Z

Total Analysts: **22**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 17 | 77% |
| Overweight | 4 | 18% |
| Hold | 1 | 5% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 101.79 |
| Highest Target | 170.00 |
| Lowest Target | 124.40 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/603259.SH/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/603259.SH/norm.md)
- [Related News](https://longbridge.com/en/quote/603259.SH/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/603259.SH/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**